Letzte Aktivitäten
- Keratinocyte FABP5 mediates saturated fat-induced MAPK/CCL20 signaling in psoriatic inflammation
- Development of a tool to measure patient-oriented outcomes for Veterans with inflammatory arthritis initiating self-administered biologic therapies
- Switching to Tildrakizumab 200 mg after Anti-IL-17 Failure in Moderate-to-Severe Psoriasis: A 52-Week Prospective Real-World Study
- An Extension Study in Patients with Moderate to Severe Plaque Psoriasis to Evaluate the Long-term Safety, Efficacy and Durability of Response to ESK-001 (ONWARD3)
- Risk of cancer in psoriasis patients treated with biologic therapy: A BADBIR cohort study
- Firearm Injury Prevention Bystander Intervention for Adolescents in Shooting Sports: A Cluster Randomized Clinical Trial
- A multicenter, open-label, prospective study to assess the concentration of bimekizumab in mature breast milk from mothers receiving treatment with Bimzelx® (bimekizumab)
- A multicenter, open-label, prospective study to assess the concentration of bimekizumab in mature breast milk from mothers receiving treatment with Bimzelx® (bimekizumab)
- A Phase 3, Randomized, Multicenter, Double-Blind, Placebo- and Active Comparator-Controlled Study With a Randomized Withdrawal and Retreatment Period to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Subjects With Moderate-to-Severe Plaque
- Dermoscopy vs. histopathology in palmoplantar psoriasis and hyperkeratotic eczema: a cross-sectional study
- CGRP levels in autoimmune diseases: a systematic review and meta-analysis of its potential role as a biomarker
- Immunomodulatory Probiotics in Psoriasis: Effects on the Gut-Skin-Immune Crosstalk and Systemic Inflammation: Immunomodulatory Probiotics and Psoriasis Disease
- Integrated Transcriptomic and Single-Cell RNA Sequencing Analyses Identify Shared Inflammation-Related Candidate Genes in Psoriasis and Acute Myocardial Infarction
- Integrative Analysis of Epidermal Barrier Dysfunction Regulators in Psoriasis
- Localized IDO Delivery via Granular PEG Hydrogel Enhances Therapeutic Control of Psoriasis
- Targeting the IL-23 pathway in inflammatory bowel disease: from cytokine inhibition to oral IL-23 receptor blockade
- The Value of Systemic Inflammatory Parameters (Neutrophil-Lymphocyte Ratio and C-Reactive Protein) Combined with Psoriasis Area Severity Index in Predicting the Development of Arthritic Symptoms in Patients with Psoriasis
- Clinical Outcomes Following Mandatory Switching to an Adalimumab Biosimilar in Patients with Psoriasis: A Real-world Single-centre Experience
- Psoriasis undercover! : Relevance of advanced diagnostics in occupational dermatology
- Cathepsin S drives keratinocyte IL-8/ICAM-1-mediated neutrophilic inflammation in generalized pustular psoriasis and induces a pustular psoriasis-like phenotype in mice